Lovastatin Tablet
Product Images NDC 70518-2009

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 70518-2009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovastatin (65abb8c3 847f 4fb3 B8de 21888c01210b 01)

FDA Label Image

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)
The text describes a graph or figure labelled as "Figure 1" which shows the proportion of participants without an event in relation to Acute Major Coronary Events. The primary endpoint is indicated on the graph, and there is a 87% risk reduction demonstrated. The years of follow-up are also indicated.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Lovastatin is a prescription drug that needs to be kept out of reach of children. It is manufactured by Lupin Pharma in Baltimore, MD and its NDC number is 70518-2009-00. The directions for use should be read from the package insert. The drug should be stored between 20-26°C (63-77°F) with excursions to 15-30°C (59-86°F). If repackaged, it's done by RemedyRepack Inc. in Indiana, PA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.